Funding

Turn ideas into impact

Viewing all 767 opportunities
Filter Options
767 results :
Filter List
Close
Update Filters
2
Type
Amount
Source
Eligibility
Status
View 767 Results
Clear All Filters

Due: March 9, 2026

Closing Soon

International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)

Type

Grant

Source

Federal

Opp Number

PAR-24-114

Due: March 10, 2026

Closing Soon

Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)

Type

Grant

Source

Federal

Opp Number

RFA-DA-26-009

Due: March 10, 2026

Closing Soon

Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)

Type

Grant

Source

Federal

Opp Number

RFA-DA-26-010

Due: March 11, 2026

Closing Soon

Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD

US $275,000

Type

Grant

Source

Federal

Due: March 12, 2026

Closing Soon

AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Clinical Scientist Career Development Award (K08)

Type

Grant

Source

Federal

Opp Number

PA-22-050

Due: March 12, 2026

Closing Soon

AHRQ Patient-Centered Outcomes Research (PCOR) Mentored Research Scientist Career Development Award (K01)

Type

Grant

Source

Federal

Opp Number

PA-22-049

Due: March 12, 2026

Closing Soon

Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required)

Type

Grant

Source

Federal

Opp Number

PAR-23-150

Due: March 12, 2026

Closing Soon

Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed)

Type

Grant

Source

Federal

Opp Number

PAR-23-149

Due: March 13, 2026

Closing Soon

HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)

US $2,500,000

Type

Grant

Source

Federal

Opp Number

PAR-24-037

Submit your funding opportunity.

Do you have a grant, incentive, funding competition, or other funding source to share?

Next up:

Facilities